Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe history now shows a new revision labeled v3.6.5, replacing the previous v3.6.4. This indicates an internal update to the page version rather than changes to the study details.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history now shows the latest revision as v3.6.4, replacing the previous v3.6.3 entry. This reflects an update to the study record version.SummaryDifference0.1%

- Check53 days agoChange DetectedNew revision entry v3.6.3 was added to the study's history, replacing the previous v3.6.2. This reflects an update to the revision history metadata rather than changes to the study content.SummaryDifference0.1%

- Check61 days agoChange DetectedThe record history shows a new revision label of v3.6.2, replacing the previous v3.6.0. This reflects an updated version of the study record.SummaryDifference0.1%

- Check75 days agoChange DetectedA new entry for Revision: v3.6.0 has been added to the revision history, signaling an updated study record version. The older Revision: v3.5.5 entry has been removed from the history.SummaryDifference0.5%

- Check82 days agoChange DetectedThe revision history now lists the latest release as v3.5.5, replacing the previous v3.5.4.SummaryDifference0.1%

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.